Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates

Bioconjugate Chemistry

Volumn 21, Issue 1, 2010, Pages 111-121

  Tong, Rong ^a   Cheng, Jianjun ^a  

^a University of Illinois at Urbana Champaign   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; MOLECULAR WEIGHT DISTRIBUTION; PARTICLE SIZE; RING OPENING POLYMERIZATION; TARGETED DRUG DELIVERY;

CAMPTOTHECINS; CONTROLLED SYNTHESIS; LACTIDE POLYMERIZATION; LACTIDES; LOADING EFFICIENCY; NANO PRECIPITATIONS; PENTAENE; POLY LACTIDE; POLYMERIZATION OF LACTIDE; STERIC BULK;

POLYESTERS;

CAMPTOTHECIN; NANOPARTICLE; POLYGLACTIN; POLYLACTIDE;

ARTICLE; CONJUGATE; CONTROLLED STUDY; IC 50; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMERIZATION;

EID: 74949141965     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900356g     Document Type: Article

References (60)

1. Muggia, F. M., Dimery, I., and Arbuck, S. G. (1996) Camptothecin and its analogs. Ann. N.Y. Acad. Sci. 803, 213-223.
2. Liehr, J. G., Giovanella, B. C., and Verschraegen, C. F. (2000) The Camptothecins: Unfolding Their Anticancer Potential (Annals of the New York Academy of Sciences), New York Academy of Sciences, New York.
3. Hertzberg, R. P., Caranfa, M. J., and Hecht, S. M. (1989) On the mechanism of topoisomerase-I inhibition by camptothecin-evidence for binding to an enzyme DNA complex. Biochemistry 28, 4629-4638.
4. Mi, Z., and Burke, T. G. (1994) Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33, 10325-10336.
5. Mi, Z., and Burke, T. G. (1994) Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study. Biochemistry 33, 12540-12545.
6. Greenwald, R. B., Pendri, A., Conover, C., Gilbert, C., Yang, R., and Xia, J. (1996) Drug delivery systems 0.2. Camptothecin 20-O-poly(ethylene glycol)ester transport forms. J. Med. Chem. 39, 1938-1940.
7. Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., and Minko, T. (2005) Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc. Natl. Acad. Sci. U.S.A. 102, 12962-12967.
8. Bhatt, R. L., de Vries, P., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., and Klein, P. (2003) Synthesis and in vivo antitumor activity of poly(L-glutamic acid) conjugates of 20(S)-camptothecin. J. Med. Chem. 46, 190-193.
9. Cabral, H., Nakanishi, M., Kumagai, M., Jang, W. D., Nishiyama, N., and Kataoka, K. (2009) A photo-activated targeting chemotherapy using glutathione sensitive camptothecin-loaded polymeric micelles. Pharm. Res. 26, 82-92.
10. Schluep, T., Cheng, J., Khin, K. T., and Davis, M. E. (2006) Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Cancer Chemother. Pharmacol 57, 654-662.
11. Cheng, J., Khin, K. T., and Davis, M. E. (2004) Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates. Mol. Pharmacol. 1, 183-193.
12. Cheng, J. J., Khin, K. T., Jensen, G. S., Liu, A. J., and Davis, M. E. (2003) Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates. Bioconjugate Chem. 14, 1007-1017.
13. Schluep, T., Hwang, J., Cheng, J., Heidel, J. D., Bartlett, D. W., Hollister, B., and Davis, M. E. (2006) Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clin. Cancer Res. 12, 1606-1614.
14. Schluep, T., Hwang, J., Hildebrandt, I. J., Czernin, J., Choi, C. H. J., Alabi, C. A., Mack, B. C., and Davis, M. E. (2009) Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proc. Natl. Acad. Sci. U.S.A. 106, 11394-11399.
15. Greenwald, R. B., Pendri, A., Conover, C. D., Lee, C., Choe, Y. H., Gilbert, C., Martinez, A., Xia, J., Wu, D. C., and Hsue, M. (1998) Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity. Bioorg. Med. Chem. 6, 551-562.
16. Moore, D. R., Cheng, M., Lobkovsky, E. B., and Coates, G. W. (2003) Mechanism of the alternating copolymerization of epoxides and CO2 using beta-diiminate zinc catalysts: Evidence for a bimetallic epoxide enchainment. J. Am. Chem. Soc. 125, 11911-11924.
17. Jeske, R. C., DiCiccio, A. M., and Coates, G. W. (2007) Alternating copolymerization of epoxides and cyclic anhydrides: An improved route to aliphatic polyesters. J. Am. Chem. Soc. 129, 11330-11331.
18. Chamberlain, B. M., Cheng, M., Moore, D. R., Ovitt, T. M., Lobkovsky, E. B., and Coates, G. W. (2001) Polymerization of lactide with zinc and magnesium beta-diiminate complexes: Stereocontrol and mechanism. J. Am. Chem. Soc. 123, 3229-3238.
19. Cheng, M., Moore, D. R., Reczek, J. J., Chamberlain, B. M., Lobkovsky, E. B., and Coates, G. W. (2001) Single-site beta-diiminate zinc catalysts for the alternating copolymerization of CO2 and epoxides: Catalyst synthesis and unprecedented polymerization activity. J. Am. Chem. Soc. 123, 8738-8749.
20. Martin-Kleiner, I., Svoboda-Beusan, I., and Gabrilovac, J. (2006) PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cells. Immunopharm. Immunotox. 28, 411-420.
21. Conover, C. D., Greenwald, R. B., Pendri, A., and Shum, K. L. (1999) Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs. Anti-Cancer Drug Des. 14, 499-506.
22. Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., and Farokhzad, O. C. (2007) Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28, 869-876.
23. Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., and Langer, R. (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 6315-6320.
24. Dechy-Cabaret, O., Martin-Vaca, B., and Bourissou, D. (2004) Controlled ring-opening polymerization of lactide and glycolide. Chem. Rev. 104, 6147-6176.
25. Coulembier, O., Degee, P., Hedrick, J. L., and Dubois, P. (2006) From controlled ring-opening polymerization to biodegradable aliphatic polyester: Especially poly(beta-malic acid) derivatives. Prog. Polym. Sci. 31, 723-747.
26. Okada, M. (2002) Chemical syntheses of biodegradable polymers. Prog. Polym. Sci. 27, 87-133.
27. Kuran, W. (1998) Coordination polymerization of heterocyclic and heterounsaturated monomers. Prog. Polym. Sci. 23, 919-992.
28. Chisholm, M. H., and Eilerts, N. W. (1996) Single-site metal alkoxide catalysts for ring-opening polymerizations. Poly(dilactide) synthesis employing {HB(3-Bu(t)pz)(3)}Mg(OEt). Chem. Commun. 853-854.
29. O'Keefe, B. J., Hillmyer, M. A., and Tolman, W. B. (2001) Polymerization of lactide and related cyclic esters by discrete metal complexes. J. Chem. Soc., Dalton Trans. 2215-2224.
30. Williams, C. K., Breyfogle, L. E., Choi, S. K., Nam, W., Young, V. G., Hillmyer, M. A., and Tolman, W. B. (2003) A highly active zinc catalyst for the controlled polymerization of lactide. J. Am. Chem. Soc. 125, 11350-11359.
31. O'Keefe, B. J., Monnier, S. M., Hillmyer, M. A., and Tolman, W. B. (2001) Rapid and controlled polymerization of lactide by structurally characterized ferric alkoxides. J. Am. Chem. Soc. 123, 339-340.
32. Tong, R., and Cheng, J. (2008) Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles. Angew. Chem., Int. Ed. 47, 4830-4834.
33. Tong, R., and Cheng, J. (2009) Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. J. Am. Chem. Soc. 131, 4744-4754.
34. 2 and propylene oxide. J. Am. Chem. Soc. 124, 14284-14285.
35. 2 and epoxides: Discovery, reactivity, optimization, and mechanism. Angew. Chem., Int. Ed. 43, 6618-6639.
36. Rieth, L. R., Moore, D. R., Lobkovsky, E. B., and Coates, G. W. (2002) Single-site beta-diiminate zinc catalysts for the ring-opening polymerization of beta-butyrolactone and betavalerolactone to poly(3-hydroxyalkanoates). J. Am. Chem. Soc. 124, 15239-15248.
37. Rowley, J. M., Lobkovsky, E. B., and Coates, G. W. (2007) Catalytic double carbonylation of epoxides to succinic anhydrides: Catalyst discovery, reaction scope, and mechanism. J. Am. Chem. Soc. 129, 4948-4960.
38. 2/epoxide polymerization: Subtle modifications resulting in superior activities. Angew. Chem., Int. Ed. 41, 2599-2602.
39. Spivey, A. C., and Andrews, B. I. (2001) Catalysis of the asymmetric desymmetrization of cyclic anhydrides by nucleophilic ring-opening with alcohols. Angew. Chem., Int. Ed. 40, 3131-3134.
40. Lu, H., Lin, H. X., Jiang, Y., Zhou, X. G., Wu, B. L., and Chen, J. M. (2006) Synthesis and antitumor activity of 20-O-linked succinate-based camptothecin ester derivatives. Lett. Drug Des. Discov. 3, 83-86.
41. Yen, Y., Synold, T., and Schluep, T. (2007) First-in-human phase I trial of a cyclodextrincontaining polymer-camptothecin nanoparticle in patients with various solid tumors. J. Clin. Oncol. 25 (Suppl. 18), 14078.
42. Heath, J. R., and Davis, M. E. (2008) Nanotechnology and cancer. Annu. Rev. Med. 59, 251-265.
43. Davis, M. E., Chen, Z., and Shin, D. M. (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discovery 7, 771-782.
44. Tong, R., and Cheng, J. (2007) Anticancer polymeric nanomedicines. Polym. Rev. 47, 345-381.
45. Tong, R., Christian, D. A., Tang, L., Cabral, H., Baker, J. R., Kataoka, K., Discher, D. E., and Cheng, J. J. (2009) Nanopolymeric Therapeutics. MRS Bull. 34, 422-431.
46. Teply, B. A., Tong, R., Jeong, S. Y., Luther, G., Sherifi, I., Yim, C. H., Khadernhosseini, A., Farokhzad, O. C., Langer, R. S., and Cheng, J. (2008) The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials 29, 1216-1223.
47. Cheng, J. J., Teply, B. A., Jeong, S. Y., Yim, C. H., Ho, D., Sherifi, I., Jon, S., Farokhzad, O. C., Khademhosseini, A., and Langer, R. S. (2006) Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Pharm. Res. 23, 557-564.
48. Musumeci, T., Ventura, C. A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., and Puglisi, G. (2006) PLA/ PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 325, 172-179.
49. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., and Watanabe, N. (2004) Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 91, 1775-1781.
50. Mu, L., and Feng, S. S. (2003) A novel controlled release formulation for the anticancer drug paclitaxel (Taxol(R)): PLGA nanoparticles containing vitamin E TPGS. J. Controlled Release 86, 33-48.
51. Avgoustakis, K. (2004) Pegylated poly(lactide) and poly(lactide-co- glycolide) nanoparticles: preparation, properties and possible application in drug delivery. Curr. Drug Delivery 1, 321-333.
52. Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., Zabinski, R. F., Meyer, D. L., and Francisco, J. A. (2004) Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin. Cancer Res. 10, 7063-7070.
53. Barenholz, Y. (2003) Relevancy of drug loading to liposomal formulation therapeutic efficacy. J. Liposome Res. 13, 1-8.
54. Missirlis, D., Kawamura, R., Tirelli, N., and Hubbell, J. A. (2006) Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur. J. Pharm. Sci. 29, 120-129.
55. Kunii, R., Onishi, H., and Machida, Y. (2007) Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin. Eur. J. Pharm. Biopharm. 67, 9-17.
56. Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Frechet, J. M. J., Dy, E. E., and Szoka, F. C. (2006) A single dose of doxorubicin- functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc. Natl. Acad. Sci. U.S.A. 103, , 16649-16654.
57. Yoo, H. S., Lee, K. H., Oh, J. E., and Park, T. G. (2000) In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J. Controlled Release 68, 419-431.
58. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y., Kataoka, K., and Inoue, S. (1990) Polymer micelles as novel drug carrier - adriamycin-conjugated poly(ethylene glycol) poly(aspartic acid) block copolymer. J. Controlled Release 11, 269-278.
59. Sengupta, S., Eavarone, D., Capila, I., Zhao, G. L., Watson, N., Kiziltepe, T., and Sasisekharan, R. (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436, 568-572.
60. Zhang, Z. P., and Feng, S. S. (2006) Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug release. Biomaterials 27, 262-270.